About US
Contact us
-
Pfizer whacks plant as generics eat salesPfizer has completely remade itself in the face of patent expirations for blockbusters likeLipitor. The drugmaker last year sold its nutrition unit toNestlé, and this year it finished the sell-off of2013/11/22
-
FDA Should Take Action on ‘Unfeasible Guidances’ to Help Boost Stagnant US Antibiotics MarketWith a diminishing antibiotics pipeline and one of the primary market needs lying in the availability of effective antibiotics for hospital-acquired pneumonia, FDA needs to take serious action to allo2013/11/21
-
GSK cashing in one-third of its stake in South Africa's AspenIf you take a big bet on an up-and-coming pharmaceutical maker and you turn out to be right, you should be able to reap some profit from your investment. That's what GlaxoSmithKline ($GSK) intends to2013/11/21
-
Bayer gets European marketing authorisation for cancer drug XofigoBayer HealthCare has received marketing authorisation from the European Commission (EC) for its Xofigo (radium-223 dichloride) injection to treat patients with castration-resistant prostate cancer (CR2013/11/20
-
Lumena receives positive COMP opinion for orphan drug designation for liver drugUS-based Lumena Pharmaceuticals has announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has issued positive opinions for four orphan drug designations for2013/11/20
-
Two more Merck plants to fall in job-reaping planMerck's manufacturing network continues to take a beating as the drugmaker acts on its $2.5 billion cost-cutting manifesto which is slated to claim 8,500 positions worldwide in the face of patent loss2013/11/19
-
Almac Further Enhances 3rd Party Logistics Commercial Support Services for Niche/Orphan DrugsAlmac, a leading provider of contract services to the global pharmaceutical and biotech industries, announces the release of an enhanced 3rd Party Logistics (3PL) Customer Billing Application. In r2013/11/19
-
Pharma in India scrambles to appease wholesalers, chemistsNobody making or selling drugs inIndiawas happy when the government this year expanded price caps to nearly 350 drugs, but there seemed little for anyone to do. When wholesalers and retailers began ho2013/11/18
-
Medix Biochemica Announces European Launch of Antibody Production ServicesMedix Biochemica, producer of monoclonal antibodies for the global IVD industry and diagnostic rapid tests, is presenting its MedixMAB by Design and MedixMAB Manufacturing antibody production services2013/11/18
-
Merck KGaA hikes forecast, eyes deals as cost cuts keep deliveringOnce again,Merck KGaAreported a quicker-than-expected payoff from its big cost-cutting program. The German drugmaker hiked its profit forecast for the year, saying the changes it has made are deliveri2013/11/15